Terms: = Sarcomas AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1 AND Prognosis
17 results:
1. miR-1293 suppresses osteosarcoma progression by modulating drug sensitivity in response to cisplatin treatment.
Wang T; Huang J; Chen G; Fu J; Li T; Zou X; Yi H
Int Immunopharmacol; 2024 Mar; 130():111702. PubMed ID: 38367464
[TBL] [Abstract] [Full Text] [Related]
2. Notch signaling regulates a metabolic switch through inhibiting PGC-1α and mitochondrial biogenesis in dedifferentiated liposarcoma.
Tien PC; Chen X; Elzey BD; Pollock RE; Kuang S
Oncogene; 2023 Aug; 42(34):2521-2535. PubMed ID: 37433985
[TBL] [Abstract] [Full Text] [Related]
3. Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma.
Jagosky MH; Anderson CJ; Symanowski JT; Steuerwald NM; Farhangfar CJ; Baldrige EA; Benbow JH; Livingston MB; Patt JC; Ahrens WA; Kneisl JS; Kim ES
Cancer Med; 2023 Mar; 12(6):7029-7038. PubMed ID: 36464833
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological and Genomic Profiles of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma Identify Overlapping Signatures with a High Mutational Burden.
Ak M; Kahraman A; Arnold FM; Turko P; Levesque MP; Zoche M; Ramelyte E; Dummer R
Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34202213
[TBL] [Abstract] [Full Text] [Related]
5. CT Attenuation and Cross-sectional-area Index of the Pectoralis Are Associated With prognosis in Sarcoma Patients.
Jo S; Sebro R
Anticancer Res; 2021 Apr; 41(4):1927-1935. PubMed ID: 33813398
[TBL] [Abstract] [Full Text] [Related]
6. MYC and notch1-positive postradiation cutaneous angiosarcoma of the breast.
Sheu TG; Hunt KK; Middleton LP
Breast J; 2021 Mar; 27(3):264-267. PubMed ID: 33527629
[TBL] [Abstract] [Full Text] [Related]
7. Post-radiotherapy vascular lesions of the breast: immunohistochemical and molecular features of 74 cases with long-term follow-up and literature review.
Corradini AG; Asioli S; Morandi L; Brotto M; Righi A; Iommi M; Agostinelli C; Rucci P; Asioli S; Sapino A; Viale G; Foschini MP
Histopathology; 2020 Aug; 77(2):293-302. PubMed ID: 32043616
[TBL] [Abstract] [Full Text] [Related]
8. miR-139-mediated notch1 regulation is crucial for the inhibition of osteosarcoma progression caused by resveratrol.
Xiao X; Zhang Y; Pan W; Chen F
Life Sci; 2020 Feb; 242():117215. PubMed ID: 31881225
[TBL] [Abstract] [Full Text] [Related]
9. Epigenetic Profiling Identifies LIF as a Super-enhancer-Controlled Regulator of Stem Cell-like Properties in Osteosarcoma.
Lu B; He Y; He J; Wang L; Liu Z; Yang J; Gao Z; Lu G; Zou C; Zhao W
Mol Cancer Res; 2020 Jan; 18(1):57-67. PubMed ID: 31615908
[TBL] [Abstract] [Full Text] [Related]
10. The Notch Pathway Promotes Osteosarcoma Progression through Activation of Ephrin Reverse Signaling.
Yu L; Xia K; Gao T; Chen J; Zhang Z; Sun X; Simões BM; Eyre R; Fan Z; Guo W; Clarke RB
Mol Cancer Res; 2019 Dec; 17(12):2383-2394. PubMed ID: 31570655
[TBL] [Abstract] [Full Text] [Related]
11. A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma.
Alegre F; Ormonde AR; Snider KM; Woolard K; Yu AM; Wittenburg LA
PLoS One; 2018; 13(12):e0209941. PubMed ID: 30596759
[TBL] [Abstract] [Full Text] [Related]
12. Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma.
Deng Y; Zhao F; Zhang Z; Sun F; Wang M
Cancer Biother Radiopharm; 2018 Nov; 33(9):365-372. PubMed ID: 29989838
[TBL] [Abstract] [Full Text] [Related]
13. SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration.
Indovina P; Casini N; Forte IM; Garofano T; Cesari D; Iannuzzi CA; Del Porro L; Pentimalli F; Napoliello L; Boffo S; Schenone S; Botta M; Giordano A
J Cell Physiol; 2017 Jan; 232(1):129-35. PubMed ID: 27037775
[TBL] [Abstract] [Full Text] [Related]
14. Histone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma.
Vleeshouwer-Neumann T; Phelps M; Bammler TK; MacDonald JW; Jenkins I; Chen EY
PLoS One; 2015; 10(12):e0144320. PubMed ID: 26636678
[TBL] [Abstract] [Full Text] [Related]
15. High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets.
Fallet V; Saffroy R; Girard N; Mazieres J; Lantuejoul S; Vieira T; Rouquette I; Thivolet-Bejui F; Ung M; Poulot V; Schlick L; Moro-Sibilot D; Antoine M; Cadranel J; Lemoine A; Wislez M
Ann Oncol; 2015 Aug; 26(8):1748-53. PubMed ID: 25969368
[TBL] [Abstract] [Full Text] [Related]
16. Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells.
De Salvo M; Raimondi L; Vella S; Adesso L; Ciarapica R; Verginelli F; Pannuti A; Citti A; Boldrini R; Milano GM; Cacchione A; Ferrari A; Collini P; Rosolen A; Bisogno G; Alaggio R; Inserra A; Locatelli M; Stifani S; Screpanti I; Miele L; Locatelli F; Rota R
PLoS One; 2014; 9(5):e96238. PubMed ID: 24797362
[TBL] [Abstract] [Full Text] [Related]
17. Targeting BMP9-promoted human osteosarcoma growth by inactivation of notch signaling.
Li R; Zhang W; Cui J; Shui W; Yin L; Wang Y; Zhang H; Wang N; Wu N; Nan G; Chen X; Wen S; Deng F; Zhang H; Zhou G; Liao Z; Zhang J; Zhang Q; Yan Z; Liu W; Zhang Z; Ye J; Deng Y; Luu HH; Haydon RC; He TC; Deng ZL
Curr Cancer Drug Targets; 2014; 14(3):274-85. PubMed ID: 24605944
[TBL] [Abstract] [Full Text] [Related]
